Article Text

Download PDFPDF
Technique of Intraperitoneal Chemotherapy Using Veress Needle in Patients With Ovarian Cancer
  1. Manjunath Laxmayya Ramarajapalli, MD, PhD*,
  2. Nalini Gurunath Kilara, MD, DM,
  3. Murali Subramanyam, MD, DM and
  4. Nitin A. R. Rao, MS
  1. *Departments of Gynaecologic Oncology,
  2. Departments of Medical Oncology, and
  3. Departments of Surgical Gastroenterology, M S Ramaiah Medical College and Hospitals, Bangalore, India.
  1. Address correspondence and reprint requests to Manjunath Laxmayya Ramarajapalli, MD, PhD, Department of Gynaecologic Oncology, MS Ramaiah Curie Centre of Oncology, New BEL Road, MSR Nagar, Bangalore. E-mail: manjunath.ramarajapalli{at}gmail.com.

Abstract

Adjuvant intraperitoneal chemotherapy in ovarian cancer has shown improved survival but limited by catheter-related complications. We present a technique of Veress needle use for intraperitoneal instillation of chemotherapy for 220 procedures in 43 patients with minimal adverse effects all managed conservatively. Our unique technique of paclitaxel instillation is described.

  • Ovarian carcinoma
  • Intraperitoneal chemotherapy
  • Veress needle
  • Membrane filter
  • Paclitaxel

Statistics from Altmetric.com

Footnotes

  • The authors declare that there are no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.